A Subdominant CD8+ Cytotoxic T Lymphocyte (CTL) Epitope from the Plasmodium yoeliiCircumsporozoite Protein Induces CTLs That Eliminate Infected Hepatocytes from Culture

ABSTRACT Previous studies indicated that the Plasmodium yoeliicircumsporozoite protein (PyCSP) 57–70 region elicits T cells capable of eliminating infected hepatocytes in vitro. Herein, we report that the PyCSP58–67 sequence contains an H-2d binding motif, which binds purified Kd molecules in vitro with low affinity (3,267 nM) and encodes an H-2d-restricted cytotoxic T lymphocyte (CTL) epitope. Immunization of BALB/c mice with three doses of a multiple antigen peptide (MAP) construct containing four branches of amino acids 57 to 70 linked to a lysine-glycine core [MAP4(PyCSP57–70)] and Lipofectin as the adjuvant induced both T-cell proliferation and a peptide-specific CTL response that was PyCSP59–67 specific, H-2d restricted, and CD8+T cell dependent. Immunization with either DNA encoding the PyCSP or irradiated sporozoites demonstrated that this CTL epitope is subdominant since it is not recognized in the context of whole CSP immunization. The biological relevance of this CTL response was underlined by the demonstration that it could mediate genetically restricted, CD8+- and nitric-oxide-dependent elimination of infected hepatocytes in vitro, as well as partial protection of BALB/c mice against sporozoite challenge. These findings indicate that subdominant epitopes with low major histocompatibility complex affinity can be used to engineer epitope-based vaccines and have implications for the selection of epitopes for subunit-based vaccines.

[1]  Richard Graham Knowles,et al.  1400W Is a Slow, Tight Binding, and Highly Selective Inhibitor of Inducible Nitric-oxide Synthase in Vitro and in Vivo* , 1997, The Journal of Biological Chemistry.

[2]  Division on Earth Guide for the Care and Use of Laboratory Animals , 1996 .

[3]  M. Tsuji,et al.  Plasmodium yoelii: peptide immunization induces protective CD4+ T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein. , 1996, Experimental parasitology.

[4]  Lunli Yuan,et al.  Comparison of cytotoxic T lymphocyte responses induced by peptide or DNA immunization: Implications on immunogenicity and immunodominance , 1997, European journal of immunology.

[5]  D. Valmori,et al.  Presentation of T-cell epitopes assembled as multiple-antigen peptides to murine and human T lymphocytes , 1993, Infection and immunity.

[6]  L. Rénia,et al.  Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection. , 1997, International immunology.

[7]  S. Hoffman,et al.  Induction of murine cytotoxic T lymphocytes against Plasmodium falciparum sporozoite surface protein 2 , 1994, European journal of immunology.

[8]  L. Rénia,et al.  In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Hoffman,et al.  Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides. , 1997, Journal of immunology.

[10]  A. Vitiello,et al.  Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes. , 1996, Journal of immunology.

[11]  S. Hoffman,et al.  Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity , 1996, The Journal of experimental medicine.

[12]  P. Romero,et al.  H-2Kd-restricted antigenic peptides share a simple binding motif , 1991, The Journal of experimental medicine.

[13]  L. Rénia,et al.  Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii , 1990, European journal of immunology.

[14]  D. Valmori,et al.  Immunodominance of cytotoxic T lymphocyte epitopes co‐injected in vivo and modulation by interleukin‐12 , 1996, European journal of immunology.

[15]  M. Selby,et al.  Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathway. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  L. Rénia,et al.  Effector functions of circumsporozoite peptide-primed CD4+ T cell clones against Plasmodium yoelii liver stages. , 1993, Journal of immunology.

[17]  V. Nussenzweig,et al.  Multiple T helper cell epitopes of the circumsporozoite protein of Plasmodium berghei , 1988, European journal of immunology.

[18]  L. Rénia,et al.  Peptide-primed CD4+ cells and malaria sporozoites. , 1990, Immunology letters.

[19]  H. Rammensee,et al.  In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine , 1989, Nature.

[20]  P. Palese,et al.  Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Bawden,et al.  Rapid, large-scale isolation of Plasmodium berghei sporozoites from infected mosquitoes. , 1979, The Journal of parasitology.

[22]  J. Sidney,et al.  Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. , 1996, Journal of immunology.

[23]  A Sette,et al.  Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes , 1996, The Journal of experimental medicine.

[24]  A Sette,et al.  The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides , 1987, Science.

[25]  M. Torres,et al.  Nomenclature for factors of the HLA system. , 2011, Bulletin of the World Health Organization.

[26]  A. Sette,et al.  Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. , 1995, Journal of immunology.

[27]  A Sette,et al.  Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. , 1994, Journal of immunology.

[28]  A Sette,et al.  Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues. , 1996, Journal of immunology.

[29]  H. Grey,et al.  Epitope selection and development of peptide based vaccines to treat cancer. , 1995, Seminars in cancer biology.

[30]  H. Schild,et al.  Efficiency of peptides and lipopeptides for in vivo priming of virus‐specific cytotoxic T cells , 1991, European journal of immunology.

[31]  S. Hoffman,et al.  Evaluation of an in vitro assay aimed at measuring protective antibodies against sporozoites. , 1990, Bulletin of the World Health Organization.

[32]  H. Grey,et al.  Structural analysis of peptides capable of binding to more than one Ia antigen. , 1989, Journal of immunology.

[33]  Antonio Lanzavecchia,et al.  Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells , 1989, European journal of immunology.

[34]  B. Nardelli,et al.  Cellular immune responses induced by in vivo priming with a lipid-conjugated multimeric antigen peptide. , 1993, Immunology.

[35]  W R Mayr,et al.  Nomenclature for factors of the HLA system, 1994. , 1994, Vox sanguinis.

[36]  P. Migliorini,et al.  Malaria vaccine: Immunization of mice with a synthetic T cell helper epitope alone leads to protective immunity , 1993, European journal of immunology.

[37]  S. Hoffman,et al.  Pan DR binding sequence provides T-cell help for induction of protective antibodies against Plasmodium yoelii sporozoites. , 1999, Vaccine.

[38]  S. Hoffman,et al.  Plasmodium yoelii: 17-kDa hepatic and erythrocytic stage protein is the target of an inhibitory monoclonal antibody. , 1995, Experimental parasitology.

[39]  R. Houghten,et al.  Peptide immunization can elicit malaria protein-specific memory helper but not proliferative T cells. , 1990, Peptide research.

[40]  A. Vitiello,et al.  Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. , 1995, The Journal of clinical investigation.

[41]  P. Romero,et al.  T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides. , 1992, Journal of immunological methods.

[42]  A. Miller,et al.  Dominance and crypticity of T cell antigenic determinants. , 1993, Annual review of immunology.

[43]  S. Hoffman,et al.  Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[44]  T. Wolfle Institute of Laboratory Animal Resources. , 1995 .

[45]  W. Ballou,et al.  Distinct T cell specificities are induced with the authentic versus recombinant Plasmodium berghei circumsporozoite protein. , 1992, Journal of immunology.

[46]  A Sette,et al.  Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. , 1996, Immunology today.